Takeda Pharmaceuticals struggles to gain FDA approval

Takeda Pharmaceuticals determined to gain FDA drug approval

  • Mon, 05/14/2012 - 1:48pm

In a country bulging with 23 million people with type 2 diabetes, Avandia and its successor, Actos, were once blockbuster drugs in the U.S.

Canada adds heart warnings to Lexapro labels

  • Mon, 05/07/2012 - 4:09pm

Serotonin reuptake inhibitor Lexapro, or Cipralex, as it’s marketed in Canada, may cause heart rhythm problems. According to Health Canada, risk increases as dosage increases.

Bayer confirms Yaz lawsuit settlements

Bayer confirms lawsuit settlements in quarterly statement

  • Tue, 05/01/2012 - 11:46am

Bayer Pharmaceuticals, a Germany based company, has confirmed in its First Quarter 2012 Stockholder’s newsletter that settlements have reached $142 million, or $218,000 per cases, for lawsuits alle

Yaz packaging and pills

Bayer settles 500 Yaz lawsuits

  • Fri, 04/27/2012 - 2:44pm

Bayer Pharmaceuticals is settling 500 Yasmin lawsuits at $220,000 per case.

Fosamax Femur Fracture Lawsuit

Health Canada issues bisphosphonate warning

On December 19th 2011, Health Canada officials issued a warning against use of bisphosphonate drugs including Fosamax®, Actonel®, and other similar bone strengtheni

FDA rejects petition to ban BPA use

Last Friday, the Food and Drug Administration announced that it would not ban bisphenol A (BPA), a chemical used for decades to line metal can

Consumer Drug Report

Most prescribed diabetes drug may slow prostate, other cancers

Research presented Saturday in Chicago at the American Association for Cancer Research’s annual meeting revealed th